02 December, 2020

Rumours Of Panaceas For COVID-19 Abound, But Some Might Do More Harm Than Good

Across the world, researchers are testing several antiviral drugs for their efficacy in treating COVID-19. So far, no therapeutic drugs have proven to be effective against the novel coronavirus.

Lethal Cocktail
There has been a spike in demand for antivirals that purportedly cure COVID-19
Photo by Getty Images
Rumours Of Panaceas For COVID-19 Abound, But Some Might Do More Harm Than Good
outlookindia.com
2020-03-29T20:29:14+05:30

After US President Trump and WhatsApp forwards endorsed the anti-malarial drug hydroxychloroquine (HCQ) to fight COVID-19, authorities and chemist associations have cautioned people against buying it—and other antiviral drugs. On March 24, the Delhi drugs control department sent out an advisory to chemists after observing that “some consumers were buying the medicines for prophylactic use”. The National Pharmaceuticals Pricing Authority of India too put out a tweet warning against self-medication.

“Only by prescription, it will be sold,” Rajiv Singhal, general secretary of the All India Organisation of Chemists and Druggists (AIOCD), told Outlook. Singhal says his association, which covers about 8.5 lakh chemists, has sent out strict instructions not to give out azithromycin, HCQ, chloroquine, lopanavir and ritonavir unless prescribed by a registered medical practitioner. “HCQ normally isn’t a medicine in high demand, but early this week there was a sudden spurt in queries,” he adds. “Rumours are creating the issue. Our...

unsub

THIS ARTICLE IS PRICELESS...

To read this piece, and more such stories in India's most exciting and exacting magazine, plus get access to our 25-year archives goldmine, please subscribe.


More from Ajay Sukumaran


Latest Magazine

December 07, 2020
content

other articles from the issue

articles from the previous issue

Other magazine section